Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CNR1 antibody (Extracellular, N-Term)

This Rabbit Polyclonal antibody specifically detects CNR1 in WB, IHC, IF, FACS, LCI and IC. It exhibits reactivity toward Rat.
Catalog No. ABIN7886237
$1,184.62
Plus shipping costs $50.00
Shipping to: United States
Delivery in 11 to 14 Business Days

Quick Overview for CNR1 antibody (Extracellular, N-Term) (ABIN7886237)

Target

See all CNR1 Antibodies
CNR1 (Cannabinoid Receptor 1 (CNR1))

Reactivity

  • 95
  • 44
  • 21
  • 8
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Rat

Host

  • 75
  • 14
  • 9
  • 3
  • 1
  • 1
  • 1
Rabbit

Clonality

  • 79
  • 25
Polyclonal

Conjugate

  • 65
  • 6
  • 4
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CNR1 antibody is un-conjugated

Application

  • 70
  • 37
  • 25
  • 15
  • 13
  • 13
  • 13
  • 10
  • 10
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS), Live Cell Imaging (LCI), Immunochromatography (IC)
  • Binding Specificity

    • 15
    • 12
    • 10
    • 9
    • 7
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 84-99, Extracellular, N-Term

    Purpose

    A Rabbit Polyclonal Antibody to Cannabinoid Receptor 1

    Cross-Reactivity

    Human, Mouse, Rat

    Predicted Reactivity

    Human - identical, mouse - 15,16 amino acid residues identical

    Characteristics

    Anti-Cannabinoid Receptor 1 (extracellular) Antibody (ABIN7043023, ABIN7044155 and ABIN7044156) is a highly specific antibody directed against an epitope of the rat CB1 receptor. The antibody can be used in western blot, immunohistochemistry, and live cell imaging applications. It has been designed to recognize CB1 in human, mouse, and rat samples.

    Purification

    Affinity purified on immobilized antigen.

    Immunogen

    NKSLSSFKENEENIQC, corresponding to amino acid residues 84-99 of rat CB1 receptor

    Isotype

    IgG
  • Application Notes

    WB: 1:200

    FC: 2.5 μg per reaction

    ICC: The optimal concentration should be determined by the user

    IHC: 1:100

    IP: The optimal concentration should be determined by the user

    Comment

    Cited Application: IHC

    Negative Control: (ABIN7235028)

    Blocking Peptide: (ABIN7235028)

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Concentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Target

    CNR1 (Cannabinoid Receptor 1 (CNR1))

    Alternative Name

    CNR1

    Background

    Synonyms: CB1, CB-R, CNR1, CB1R, CANN6, Brain-type cannabinoid receptor, Central cannabinoid receptor

    Description: Cannabinoids have been used in Eastern medicine for many years as pain relievers.1 Δ9-tetrahydrocannabinol (THC), the major psychoactive compound in marijuana and hashish, has been shown to interact with two specific cannabinoid receptors: cannabinoid receptor 1 (CB1 receptor) and cannabinoid receptor 2 (CB2 receptor).2 The cannabinoid receptors can be distinguished by their amino acid sequences, signaling mechanisms, and tissue distributions.2 Both receptors belong to the G-protein coupled receptor (GPCR) superfamily. CB1 was shown to modulate several Ca2+ and K+ ion channels.2,3CB1 is primarily expressed in the central nervous system. However, expression of CB1 is also detected in the peripheral terminals, in non-neuronal peripheral tissues such as uterus, testes, spleen, as well as in cells of the immune system.3,4CB1 is implicated in many cellular functions such as neurotransmitter release, pain relief, cancer, and obesity.5,6 Growth inhibition of tumor cells was demonstrated following mixed CB1/CB2 agonist treatment in both prostate and non-melanoma skin cancers.5,6 Through their interaction with CB1, cannabinoid compounds stimulate appetite for sweets and palatable foods in particular, making CB1 an attractive therapeutic target for the treatment of obesity and eating disorders.7

    Gene ID

    25248

    NCBI Accession

    NM_001160226

    UniProt

    P20272

    Pathways

    Feeding Behaviour
You are here:
Chat with us!